By API User
Professor Matthew Kiernan AM CEO at Neuroscience Research Australia is available to provide expert comment on the development of an early blood test to predict dementia, as reported by the Guardian today based on research published in nature aging. Professor Kiernan AM is an expert in neurodegenerative diseases, particularly motor neuron disease (MND) and frontotemporal dementia … Continued
By API User
A cannabis extract has shown positive results in slowing down melanoma cell growth and increasing cell death rates, a new in-vitro study finds. Researchers from Charles Darwin University (CDU) and RMIT investigated programmed cell death caused by a specific cannabis extract (cannabinoid PHEC-66) from the cannabis sativa plant. The study that was part of a PhD project … Continued
By API User
Researchers at the BioMed X Institute and the Universitätsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in diffuse midline glioma in Science Advances. HEIDELBERG, GERMANY / ACCESSWIRE / February 6, 2024 / BioMed X and the Universitätsmedizin Mannheim announced today the publication of two manuscripts in the field of … Continued
By API User
Elixinol Wellness Limited (ASX: EXL) continues to be a pioneer in the global hemp industry, with the release of a new paper into the safety of Elixinol Hemp Extract in leading scientific publication, Journal of Toxicology. The paper, entitled “Safety of Elixinol Hemp Extract: In VitroGenetic Toxicity and Subchronic Toxicity in Rat”, reports on safety studies of Elixinol … Continued
By API User
Dr Steve Kassem from Neuroscience Research Australia is available to provide his expert comment on Elon Musk’s Neuralink. Dr Kassem is a brain cartographer and works at NeuRA’s Brain Mapping Facility with Professor George Paxinos AO. He is an experienced media spokesperson, having appeared on radio and television numerous times, as well as being a … Continued
By API User
BlinkLab, the groundbreaking early detection diagnostic tool for Autism and other neurological disorders, is pleased to announce the appointments of Jane Morgan as a Non-Executive Director and Brian Leedman as Chairman of the Board. These significant additions to the board come as BlinkLab prepares for listing on the Australian Securities Exchange (ASX), with Westar Capital … Continued
By API User
TRONDHEIM, NORWAY / ACCESSWIRE / January 17, 2024 / Chiron AS, a leading producer of chemical reference materials headquartered in Trondheim, Norway, is pleased to announce the establishment of a state-of-the-art research centre dedicated to the enhanced surveillance of environmental pollutants. This ground-breaking development, supported by an estimated 40 million NOK investment, reaffirms Chiron’s commitment … Continued
By API User
Following the first official announcement at the beginning of December last year, Hyris completed the transfer of its shares into Ulisse Biomed via a reverse take-over transaction. The new group, strong of flawless interoperability between its leading technologies, aims to become a new benchmark of innovation in the national and international biotech market. LONDON, ENGLAND … Continued
By API User
La Trobe University is launching its first major spin-out company with technology that is set to revolutionise medical imaging and potentially save millions of lives. AlleSense has been created to support the commercialisation of technology invented by La Trobe researchers Professor Brian Abbey and Dr Eugeniu Balaur, from the School of Computing, Engineering and … Continued
By API User
LUXEMBOURG / ACCESSWIRE / December 14, 2023 / Moolec Science SA (NASDAQ:MLEC), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the first quarter of Fiscal Year 2024 ended September 30, 2023. The main highlights of Moolec’s business update are as follows: … Continued
